Our practice

The Deloitte Touche Tohmatsu (DTT) Life Sciences and Health Care (LSHC) industry group, made up of the LSHC specialists from DTT member firms, is comprised of more than 4,000 professionals in over 47 countries. Their understanding of the industry’s challenges and their ability to quickly respond with integrated, comprehensive services put the DTT Member firms in a unique position to help their clients. These professionals can help companies in their efforts to bring discoveries to life and improve the quality of care while they create and sustain long-term, bottom-line profitability.

In July 2008, Recombinant Capital, Inc. was purchased by Deloitte LLP and is now known as Deloitte Recap LLC (Recap). Recap offers biopharmaceutical business intelligence subscription tools and consulting services tailored toward business development, corporate strategy, financial, legal, academic and R&D professionals.

Recap recently launched a new series of biopharmaceutical business intelligence tools, the Recap IQ Series by Deloitte™, providing analytical tools to help life sciences companies leverage comprehensive biopharma alliance data, deal values, and drug development histories to support the development of alliance and clinical development strategies.

Our clients

DTT Member firms provide professional services to:

92 percent of the life sciences and health care companies in the 2009 Fortune Global 500
Nearly 85 percent of the life sciences and health care companies in the 2008 Fortune U.S. 1000
All of the ten largest medical equipment manufacturers
8 of the 10 largest biotechnology companies
All of the fifteen largest pharmaceutical manufacturers
Leading public and private health care services entities & companies around the globe

The Luxembourg firm has a team of professionals serving various facets of the life sciences & health care industry who have acquired broad industry expertise. It has recently been strengthened with additional life sciences & health care experiences, in particular through projects in organisational, human capital and IT areas, for clients such as:

Centre Hospitalier de Luxembourg (CHL)
Entente des Hôpitaux Luxembourgeois (EHL)
Pfizer
Johnson&Johnson

A collaborative approach

Deloitte is actively involved in a number of initiatives and collaboration with various international organisations and health entities.

	Deloitte Luxembourg is a sponsor of the MEDICA Trade Fair in Düsseldorf, Germany
	An ongoing collaboration has been established with the Economist Intelligence Unit (EIU) for surveying life sciences executives on the future of the life sciences industry.
	A long-standing relationship is sustained with the Forum’s health care governors group to analyse topics such as emerging markets issues and innovations in the area of health care.
	Deloitte is a long standing member of the Biotechnology Industry Organization. Deloitte professionals participate as moderators and panellists at the annual BIO Convention, an event which is attended by over 20,000 industry executives. Recently, Deloitte also participated in the Luxembourg Bioconference.
	Deloitte is a prominent sponsor of the BioPartnering Europe, an event that provides partnering and networking opportunities for decision-makers from leading biotechnology, pharmaceutical, and investment companies from around the world through one-to-one partnering meetings, presentations, expert panels and exhibitions.
	Forbes Insights is a new program for FY10 that will develop three spot surveys of current ‘top of mind’ industry topics related to life sciences and health care.